{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:48:23Z","timestamp":1771573703112,"version":"3.50.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>There are few data on the on post-treatment experiences of people who have been successfully treated for rifampicin-resistant (RR-)TB.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>To describe the experiences and impact of RR-TB disease and therapy on post-treatment life of individuals who were successfully treated.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In this qualitative study in-depth interviews were conducted among a purposively selected sample from a population of individuals who were successfully treated for RR-TB between January 2008 and December 2018. Interview transcripts and notes were analysed using a thematic network analysis which included grounded theory and a framework for understanding pathophysiological mechanisms for post-TB morbidity and mortality. The analysis was iterative and the coding system developed focused on disease, treatment and post-treatment experiences of individuals. This paper follows the COREQ guidelines.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>For all 12 participants interviewed, the development of RR-TB disease, its diagnosis and the subsequent treatment were a major disruption to their lives as well as a transformative experience. On diagnosis of RR-TB disease, participants entered a liminal period in which their lives were marked with uncertainty and dominated by physical and mental suffering. Irrespective of how long ago they had completed their treatment, they all remembered with clarity the signs and symptoms of the disease and the arduous treatment journey. Post-treatment participants reported physical, social, psychological and economic changes as consequences of their RR-TB disease and treatment. Many participants reported a diminished ability to perform physical activities and, once discharged from the RR-TB hospital, inadequate physical rehabilitation. For some, these physical limitations impacted on their social life, and ultimately on their psychological health as well as on their ability to earn money and support their families.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The experiences and impact of RR-TB disease and therapy on post-treatment life of individuals successfully treated, highlights gaps in the current health care system that need to be addressed to improve the life of individuals post-treatment. A more holistic and long-term view of post-TB health, including the provision of comprehensive medical and social services for post-treatment care of physical ailments, social re-integration and the mitigation of the perceived fear and risk of getting TB again could be a central part of person-centred TB care.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0251482","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T02:44:32Z","timestamp":1634611472000},"page":"e0251482","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["\u201cThis is not my body\u201d: Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis"],"prefix":"10.1371","volume":"16","author":[{"given":"Marian","family":"Loveday","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindisiwe","family":"Hlangu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee-Megan","family":"Larkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Mohr-Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-7199","authenticated-orcid":true,"given":"Jennifer","family":"Furin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"pone.0251482.ref001","unstructured":"World Health Organization. Global Tuberculosis Report 2020. Licence: CC BY-NC-SA 3.0 IGO. Geneva."},{"key":"pone.0251482.ref002","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis. 2013 revision, updated December 2014 and January 2020. https:\/\/www.who.int\/tb\/publications\/definitions\/en\/. Geneva, Switzerland"},{"key":"pone.0251482.ref003","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(19)30309-3","article-title":"Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis","volume":"19","author":"K Romanowski","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"pone.0251482.ref004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5588\/ijtld.14.0427","article-title":"Z. M. Mortality after tuberculosis treatment completion: results of long-term followup","volume":"20","author":"J Shuldiner","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0251482.ref005","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2105\/AJPH.2014.302431","article-title":"Mortality Hazard and Survival After Tuberculosis Treatment","volume":"105","author":"TL Miller","year":"2015","journal-title":"American Journal of Public Health"},{"key":"pone.0251482.ref006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijid.2019.05.024","article-title":"Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: A pilot study","volume":"85","author":"M Osman","year":"2019","journal-title":"Int J Infect Dis"},{"key":"pone.0251482.ref007","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1590\/s1806-37562016000000053","article-title":"Impaired pulmonary function after treatment for tuberculosis: the end of the disease?","volume":"43","author":"MI Chushkin","year":"2017","journal-title":"Jornal brasileiro de pneumologia: publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia"},{"key":"pone.0251482.ref008","doi-asserted-by":"crossref","first-page":"e0217289","DOI":"10.1371\/journal.pone.0217289","article-title":"Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD","volume":"14","author":"AN Gupte","year":"2019","journal-title":"PLoS One"},{"key":"pone.0251482.ref009","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5588\/ijtld.20.0488","article-title":"Post-tuberculosis sequelae: the need to look beyond treatment outcome","volume":"24","author":"D Visca","journal-title":"The International Journal of Tuberculosis and Lung Disease 2020"},{"key":"pone.0251482.ref010","doi-asserted-by":"crossref","first-page":"e0204697","DOI":"10.1371\/journal.pone.0204697","article-title":"Tuberculosis patients are physically challenged and socially isolated: A mixed methods case-control study of Health Related Quality of Life","volume":"13","author":"AA Roba","year":"2018","journal-title":"Eastern Ethiopia. PLoS One"},{"key":"pone.0251482.ref011","doi-asserted-by":"crossref","first-page":"e0240457","DOI":"10.1371\/journal.pone.0240457","article-title":"Burden of stigma among tuberculosis patients in a pastoralist community in Kenya: A mixed methods study","volume":"15","author":"GW Mbuthia","journal-title":"PLoS One 2020"},{"key":"pone.0251482.ref012","first-page":"76","article-title":"A very humiliating illness","volume":"20","author":"J Furin","journal-title":"South Africa. BMC Public Health 2020"},{"key":"pone.0251482.ref013","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2458-13-595","article-title":"Life experiences of patients who have completed tuberculosis treatment: a qualitative investigation in southeast Brazil","volume":"13","author":"AA Dias","year":"2013","journal-title":"BMC Public Health"},{"key":"pone.0251482.ref014","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"J Furin","year":"2019","journal-title":"Tuberculosis. Lancet"},{"key":"pone.0251482.ref015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/pon.3088","article-title":"Depression and cancer survivorship: importance of coping self-efficacy in post-treatment survivors","volume":"22","author":"EJ Philip","year":"2013","journal-title":"Psycho-oncology"},{"key":"pone.0251482.ref016","first-page":"356","volume":"30","author":"S Dauphin","journal-title":"Using Liminality and Subjunctivity to Better Understand How Patients With Cancer Experience Uncertainty Throughout Their Illness Trajectory. Qual Health Res"},{"key":"pone.0251482.ref017","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.1365-2648.2012.05995.x","article-title":"Liminality as a framework for understanding the experience of cancer survivorship: a literature review","volume":"68","author":"E Blows","year":"2012","journal-title":"J Adv Nurs"},{"key":"pone.0251482.ref018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0898010113498823","article-title":"al e. Stories of liminality: living with life-threatening illness","volume":"32","author":"A Bruce","year":"2014","journal-title":"Journal of Holistic Nursing"},{"key":"pone.0251482.ref019","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0277-9536(98)00248-2","article-title":"Liminality: a major category of the experience of cancer illness","volume":"47","author":"M Little","year":"1998","journal-title":"Soc Sci Med"},{"key":"pone.0251482.ref020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/01459740.2012.751384","article-title":"Tuberculosis is a threshold: the making of a social disease in post-Soviet Georgia","volume":"32","author":"E Koch","year":"2013","journal-title":"The Journal of Medical Anthropology"},{"key":"pone.0251482.ref021","year":"2011","journal-title":"National Planning Commission. National Development Plan: Vision for"},{"key":"pone.0251482.ref022","author":"J Corbin","year":"2008","journal-title":"Basics of qualitative research: techniques and procedures for developing grounded theory"},{"key":"pone.0251482.ref023","first-page":"423","volume":"37","author":"SW Gibbons","year":"2014","journal-title":"Liminality as a"},{"key":"pone.0251482.ref024","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1473-3099(19)30387-1","article-title":"Healthy survival after tuberculosis","volume":"19","author":"S Datta","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"pone.0251482.ref025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/146879410100100307","volume":"1","author":"J Attride-Stirling","year":"2001","journal-title":"Qual Res"},{"key":"pone.0251482.ref026","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/nhs.12048","volume":"15","author":"M Vaismoradi","year":"2013","journal-title":"Nursing Health Sciences"},{"key":"pone.0251482.ref027","first-page":"59","volume":"18","author":"G Guest","year":"2006","journal-title":"How many"},{"key":"pone.0251482.ref028","first-page":"1893","volume":"52","author":"B Saunders","year":"2018","journal-title":"Saturation"},{"key":"pone.0251482.ref029","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"a 32-item checklist for interviews and focus groups","volume":"19","author":"A Tong","year":"2007","journal-title":"International Journal for Quality in Health Care"},{"key":"pone.0251482.ref030","year":"2015","journal-title":"Introduction of new drugs and drug regimens for the management of DR-TB in South Africa: Policy Framework"},{"key":"pone.0251482.ref031","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00063198-200105000-00008","article-title":"Tuberculosis in disadvantaged groups","volume":"7","author":"J Grange","year":"2001","journal-title":"Curr Opin Pulm Med"},{"key":"pone.0251482.ref032","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.socscimed.2009.03.041","article-title":"Drivers of tuberculosis epidemics: the role of risk factors and social determinants","volume":"68","author":"K L\u00f6nnroth","year":"2009","journal-title":"Soc Sci Med"},{"key":"pone.0251482.ref033","first-page":"15","volume":"2","author":"K Rasanathan","year":"2011","journal-title":"The social determinants of health: Key to global tuberculosis control. Int J Tuberc Lung Dis"},{"key":"pone.0251482.ref034","first-page":"1160","article-title":"Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis","volume":"110","author":"M Loveday","journal-title":"South Africa. SAMJ 2020"},{"key":"pone.0251482.ref035","article-title":"Addressing stigma in people living with drug-resistant tuberculosis in India\u2013a Photovoice study","author":"T Mahbub","journal-title":"India: M\u00e9decins Sans Fronti\u00e8res"},{"key":"pone.0251482.ref036","first-page":"e0167559","volume":"12","author":"S Khanal","year":"2017","journal-title":"Development of a Patient-Centred"},{"key":"pone.0251482.ref037","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1466-7657.2006.00490.x","volume":"53","author":"K Chalco","year":"2006","journal-title":"Int Nurs Rev"},{"key":"pone.0251482.ref038","first-page":"343","volume":"7","author":"E Palacios","year":"2003","journal-title":"The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis"},{"key":"pone.0251482.ref039","first-page":"e0192983","volume":"13","author":"MH Kim","year":"2018","journal-title":"Burnout and self"},{"key":"pone.0251482.ref040","article-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis","author":"World Health Organization","year":"2014","journal-title":"WHO\/HTM\/TB\/"},{"key":"pone.0251482.ref041","year":"2013","journal-title":"South African Department of Health. Management of drug-resistant tuberculosis. Policy Guidelines"},{"key":"pone.0251482.ref042","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0140-6736(20)32340-0","volume":"396","author":"A Cieza","year":"2019","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T02:45:25Z","timestamp":1634611525000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251482"}},"subtitle":[],"editor":[{"given":"Md Nazirul Islam","family":"Sarker","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0251482","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]}}}